Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:14 PM
Ignite Modification Date:
2026-03-26 @ 3:14 PM
NCT ID:
NCT07411859
Eligibility Criteria:
Inclusion Criteria:
* Male or Female, 18-89 years old
* Treated on site for ABHP
* Willing to self-administer tDCS and complete the measures
* PEG pain intensity of 4 or more for most of the day at least 3 days per week
* Have an established PCP (Primary Care Provider) or pain management provider
Exclusion Criteria:
* Implanted pacemaker
* Seizure Disorder
* Pregnancy, if applicable
* Any new onset of the following:
* Balance Problems
* Difficulty walking
* Bladder incontinence
* Bowel incontinence
* Numbness
* Tingling
* Weakness
* Medical contraindications
* Current use of sodium channel blockers
* Lidocaine (OTC/transdermal delivery is ok)
* Mexiletine
* Amitriptyline; other tricyclic antidepressants
* Anti-epileptic medications: phenytoin, carbamazepine, lamotrigine, oxcarbazepine, rufinamide, lacosamide and eslicarbazepine acetate
* Current use of calcium channel blockers
* Current use of N-Methyl-D-aspartate receptor antagonists
* Ketamine
* Dextromethorphan
* Felbamate
* History of brain surgery
* History of brain tumor
* History of seizure disorder
* History of stroke
* Intracranial metal implantation
* Adults unable to consent
* Individuals who are not yet adults
* Prisoners
* Non-English speaking
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT07411859
Study Brief:
Protocol Section:
NCT07411859